TrialThe Journal of infectious diseases2011

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

Paul A Goepfert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.